InsidersTradesSigma
Follow the 维康药业 stock price and the full management transaction log of the company, a listed equity based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 维康药业 has recorded 2 reports. Market capitalisation: €3.8bn. The latest transaction was reported on 1 November 2022 (Sale). Among the most active insiders: 戴德雄. The full history is accessible without an account.
2
Insider Decl.
n/a
Thresholds
€268,810
1 ops.
Buy Volume
€109,630
1 ops.
Sell Volume
12Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,908 of 29,064 companies
29.0
score / 100
Value29
Quality29
FCF yld-0.0%
Earn yld-6.1%
EV/EBITDA·
ROE-21%
Gross mgn31%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 November 2022
关于 维康药业
维康药业是一家在健康和制药领域运营的公司，在 XSHE 市场上市。它专注于创新药物的开发和生产。